VC-LEG-0200 — Intellectual Property: Engineered Cultivars & Compounds

1. Purpose & Strategy

1.1. The intellectual property of GreenWorld Sector-7 is its principal asset. The living collection has value because it is novel, because that novelty is documented, and because the means of its creation are not known to others. This Policy exists to capture, protect, and lawfully exploit that value through the complementary instruments of plant patents, cultivar rights, and trade secrets.

1.2. Layered protection strategy. The Directorate protects each asset by the instrument that maximizes durable advantage: patents and registered cultivar rights for the engineered phenotype where public disclosure is acceptable; trade secret for the extraction and synthesis processes, which derive their value from secrecy and shall never be disclosed in a patent specification.

2. Defined Terms

3. Ownership & Vesting

• 3.1. All IP Assets conceived, reduced to practice, or stabilized by any person while engaged by GreenWorld Sector-7 vest in GreenWorld Sector-7 immediately upon creation, by assignment executed at onboarding.
• 3.2. This vesting extends to improvements, derivatives, and progeny of any Engineered Cultivar, including spontaneous variants observed within the collection.
• 3.3. Personnel shall promptly disclose every potentially protectable creation to LEG-IP via an Invention Disclosure Record; non-disclosure is a violation under VC-LEG-0100 §9.
• 3.4. No personnel may file, license, publish, or assign any IP Asset in a personal capacity.

4. Plant Patents & Cultivar Rights

4.1. Engineered Cultivars are protected by the strongest available combination of plant patent (covering the asexually or sexually reproduced novel variety) and registered cultivar rights under the Genetic Resource & Cultivar Rights Convention (GRCRC).

4.2. Disclosure discipline. A patent specification discloses only the phenotype and breeding outcome sufficient for grant. It shall not disclose the Extraction Process, the toxin-yield parameters, or any CHLOROPHYLL-classified datum. Where protecting the phenotype would necessarily reveal a trade secret, LEG-IP shall recommend trade-secret protection instead and the Principal Inventor and General Counsel shall jointly decide.

4.3. Cultivar names are selected by the Directorate and registered as marks where commercially exploited.

5. Trade-Secret Protection of Extraction Processes

5.1. The Extraction Processes — the precise reactor conditions, catalysts, sequencing, and yield-optimization know-how that turn a contained specimen into a usable Compound — are the Directorate's most valuable and most jealously guarded IP. They are protected exclusively as trade secrets and are never patented, published, or otherwise disclosed.

5.2. Reasonable-measures program. Trade-secret status is sustained only by demonstrable protective measures. GreenWorld Sector-7 maintains:

• Strict need-to-know access to each Extraction Process, enforced at the MDF and logged.
• Compartmentalization so that no single individual below the Principal Inventor and CBO holds a complete process.
• Classification of all process records as CHLOROPHYLL-EYES-ONLY under VC-LEG-0300.
• Binding non-disclosure obligations surviving termination indefinitely.
• Exit debrief and credential revocation for any departing person with process access.

6. Inventorship

6.1. Inventorship is a legal determination based on conception, not on seniority or funding. LEG-IP records inventorship for every IP Asset in the Invention Disclosure Record at the time of conception.

6.2. Principal Inventor. The originating scientific conception across the engineered-cultivar and toxin-compound programs is attributed to Dr. Pamela L. Isley, Ph.D. (Chief Botanical Officer), recorded as Principal Inventor on the foundational filings and as a named inventor on derivative work to which she contributed conception. Co-inventors are named where their contribution meets the conception standard; mere reduction to practice does not confer inventorship.

6.3. Inventorship recognition is honorific and scientific; it does not alter the ownership vesting in Section 3. Inventor-incentive awards are administered separately by the Directorate.

7. Representative IP Asset Register

7.1. The following is a representative extract of the IP Asset register maintained by LEG-IP. The full register is access-controlled and reconciled quarterly against the collection catalog.

8. Licensing Out

8.1. GreenWorld Sector-7 may license selected IP Assets to external parties for revenue, strategic partnership, or regulatory benefit-sharing. The Directorate licenses sparingly and never grants more than is strictly bargained for.

• 8.2. Extraction Process trade secrets are never licensed out; only finished Compounds or registered Cultivars may be the subject of a license.
• 8.3. Every outbound license shall be field-of-use limited, term-limited, audit-bearing, and non-sublicensable without written consent.
• 8.4. Licenses for any GCL-3 or GCL-4 derived material require Directorate authorization per VC-LEG-0500 and an export determination under the CBPA.
• 8.5. Every license shall include immediate-termination-for-misuse and return-of-materials provisions consistent with VC-LEG-0300.

9. Defensive Measures & Enforcement

9.1. LEG-IP maintains a defensive posture against infringement, misappropriation, and inadvertent loss of protection:

• Watch service for competing cultivar registrations and patent filings in adjacent phenotypes.
• Genetic-marker tagging of distributed Cultivars to evidence provenance in any infringement claim.
• Defensive publication of non-core variants to deny competitors patentable ground without exposing trade secrets.
• Standing instructions to external counsel (Belladonna & Vane LLP) to pursue injunctive relief on confirmed misappropriation.
• Coordination with Risk & Liability where an IP loss event is also a data-breach or containment event.

10. Revision History